Sildenafil Citrate USP
CGMP Deviations:Noted during FDA inspection
Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.
Labeling: Incorrect or missing lot and/or expiration date. Products were compounded using expired components.
Cause type: Labeling / mix-up
Wrong label, wrong strength, mixed-up products, or packaging errors. One of the most dangerous causes - you can end up taking the wrong drug or the wrong dose. All labeling / mix-up recalls.
Sildenafil 200 mg Troche (Clinic)
Drug: Sildenafil
Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.
CGMP Deviations:Noted during FDA inspection
CGMP Deviations:Noted during FDA inspection
Product mix-up: Bottles of sildenafil and trazodone were inadvertently packaged together during bottling at a 3rd party facility.
Lack of Processing Controls (lack of assurance of conformity to specifications).
Labeling: Incorrect or missing lot and/or expiration date. Products were compounded using expired components.
Labeling: Incorrect or missing lot and/or expiration date. Products were compounded using expired components.
Labeling: Incorrect or missing lot and/or expiration date. Products were compounded using expired components.
Labeling: Incorrect or missing lot and/or expiration date. Products were compounded using expired components.
Labeling: Incorrect or missing lot and/or expiration date. Products were compounded using expired components.
Free recall alerts
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.